This inventor holds 1 USPTO granted patent. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Biography of Toshikatsu Matsuyama
Introduction: Toshikatsu Matsuyama is a notable inventor based in Sapporo, Japan. He is recognized for his contributions to the field of medicine, particularly in the treatment of osteoporosis.
Latest Patents: Matsuyama holds a patent for a method for the treatment of osteoporosis. This therapeutic agent is derived from an extract of inflammatory rabbit skin inoculated with vaccinia virus. It has shown excellent efficacy in maintaining bone volume and strength in ovariectomized rats, which serve as a model for osteoporosis caused by decreased estrogen levels. The agent is particularly useful for women experiencing osteoporosis due to menopause or ovariectomy, and it boasts a high safety profile even with long-term administration.
Career Highlights: Matsuyama has made significant strides in pharmaceutical research, focusing on innovative treatments for bone health. His work has the potential to improve the quality of life for many individuals suffering from osteoporosis.
Collaborations: Throughout his career, Matsuyama has collaborated with various professionals in the field, including his coworker Jin-emon Konishi. Their joint efforts have contributed to advancements in therapeutic solutions for osteoporosis.
Conclusion: Toshikatsu Matsuyama's innovative approach to treating osteoporosis highlights the importance of research and development in the medical field. His patent represents a significant advancement in the treatment options available for individuals affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile